Eric Jay Feldman

9.4k citations
189 papers · 7.7k · 1 hit paper · h-index 44

Impact in

  • Hematology top 0.1%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Multiple Myeloma Research and Treatments
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 0.5%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Acute Myeloid Leukemia Research 99
    • Chronic Myeloid Leukemia Treatments 35
    • Multiple Myeloma Research and Treatments 18
    • Chronic Lymphocytic Leukemia Research 25

Eric Jay Feldman

181 papers receiving 7.5k citations

Eric Jay Feldman's Hit Papers

Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion 2006 · 1.1k citations
1.1k0+6+13Years since publication2505007501000

Peers

Eric Jay Feldman
Comparison fields: 5 of 118
  • Hematology 4.7k
  • Genetics 1.8k
  • Oncology 1.4k
  • Molecular Biology 3.0k
  • Pathology and Forensic Medicine 636
Replace Jeffrey E. Lancet with:
Jeffrey E. Lancet United States
Gerrit Jan Schuurhuis Netherlands
Todd A. Busman United States
Karen W L Yee Canada
Ahmed Hamed Salem United States
William G. Blum United States
Stephen Anthony Strickland United States
Walter E. Aulitzky Germany
Stanley R. Frankel United States
Bruce Douglas Smith United States
Eric Jay Feldman relative to Jeffrey E. Lancet United States Jeffrey E. Lancet's profile →
Citations per field
00.5×1.5×
Jeffrey E. Lancet · 1×
Citations per year

Countries citing papers authored by Eric Jay Feldman

Since Specialization
Citations

This map shows the geographic impact of Eric Jay Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Jay Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Jay Feldman more than expected).

Fields of papers citing papers by Eric Jay Feldman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Jay Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Jay Feldman. The network helps show where Eric Jay Feldman may publish in the future.

Co-authors

The 25 scholars most cited alongside Eric Jay Feldman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric Jay Feldman Line = papers co-authored together Eric Jay Feldman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 189 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion
Hit paper breakdown →
20061079
2 2010441
3 2007356
4 2014298
5 2011273
6 2005239
7 2005217
8 2004199
9 2008198
10 1996165
11
Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
1990161
12 2014154
13 2006143
14 2012127
15 2012111
16 2011109
17 2007108
18 2011106
19 199299
20 201296

About Eric Jay Feldman

Eric Jay Feldman is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 189 papers that have together received 7.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (99 papers), Chronic Myeloid Leukemia Treatments (35 papers), Acute Lymphoblastic Leukemia research (30 papers), Chronic Lymphocytic Leukemia Research (25 papers), Histone Deacetylase Inhibitors Research (18 papers), Multiple Myeloma Research and Treatments (18 papers), Retinoids in leukemia and cellular processes (17 papers) and Protein Degradation and Inhibitors (15 papers). The work is most often cited by research in Hematology (4.7k citations), Genetics (1.8k citations), Oncology (1.4k citations), Molecular Biology (3.0k citations) and Pathology and Forensic Medicine (636 citations). Eric Jay Feldman has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Richard Maury Stone, Gail J. Roboz, Alan F. List, Karen P. Seiter, Peter L. Greenberg, Tauseef Ahmed, Azra Raza, John M. Bennett, Robert Knight and Michele Schmidt. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia Research, Acta Haematologica and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact